Sanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, ...

Big Tech and auto shares rose after the U.S. removed smartphones and other electronics from its tariffs on China over the ...

Listed on the TSX Venture Exchange under the trading symbol “RX”, BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative ...

Despite a challenging 2024 for Boston’s life sciences market—marked by softening fundamentals and an oversupply of lab ...

Trump launched investigations to justify tariffs on pharmaceutical and semiconductor imports, citing national security ...

The stock's fall snapped a six-day winning streak.

This was the stock's second consecutive day of gains.

TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform ...

New York, New York-- (Newsfile Corp. - April 14, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BigBear.ai Holdings, Inc. (NYSE: BBAI) ...

This milestone further strengthens Nexalin’s intellectual property portfolio and affirms the potential of its proprietary Deep Intracranial Frequency Stimulation (DIFS™) technology, a non-invasive and ...

Pfizer on Monday said it had discontinued the development of the experimental weight-loss pill danuglipron after a trial ...